Among the probable processes accountable for this condition, it was reported that CLL cells may deliver soluble BAG6 (i.e., NKp30-ligand) and can challenge the exosome-bound BAG6 to stimulate NK cells via NKp30 [175]. The gene discussed is NCR3; the disease is B-cell chronic lymphocytic leukemia.